The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.00
Bid: 314.00
Ask: 315.80
Change: -0.40 (-0.13%)
Spread: 1.80 (0.573%)
Open: 307.00
High: 315.40
Low: 307.00
Prev. Close: 314.40
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share repurchase programme

26 Feb 2020 10:01

RNS Number : 1893E
Ascential PLC
26 February 2020
 

 

 

 

26 February 2020

 

 

Ascential plc ("the Company")

Share repurchase programme

 

Pursuant to the authority granted at the Annual General Meeting of the Company held on 8 May 2019, the Company announces it entered into a non-discretionary agreement with Numis Securities Limited ("Numis") on 25 February 2020 in relation to the purchase by Numis, acting as principal, of the Company's ordinary shares of 1 pence each ("Ordinary Shares") for an aggregate purchase price of up to £120m (the "Programme") and not exceeding 40,277,568 ordinary shares of 0.01p each, representing approximately 9.99% per cent. of its current issued ordinary share capital.

The Company commenced the buyback programme on Tuesday 25 February 2020.

Any purchase of shares done in relation to this announcement will be carried out on the London Stock Exchange and will be effected within certain pre-set parameters.

Ascential's shareholders generally authorised Ascential to purchase Ordinary Shares at its 2019 Annual General Meeting held on 8 May 2019, subject to certain limitations (the "Authority"). The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the Authority. The Programme will be executed in accordance with (and subject to the limits prescribed by) the Authority and will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 and in accordance with Chapter 12 of the Listing Rules.

The Company will announce any market repurchase of shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. The purpose of the Programme is to reduce the share capital of the Company. All Shares purchased will be cancelled.

The total number of voting rights in the Company on 25 February 2020 was 403,274,977.

 

Name and contact details for enquiries:

Louise Meads, Company Secretary +44 (0) 20 7516 5042

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSTFMLTMTATMPM
Date   Source Headline
5th Jan 20217:00 amRNSAppointment of Non-Executive Directors
16th Dec 20207:00 amRNSAcquisition of Digital Commerce businesses
15th Dec 20204:34 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSSale of Glenigan for £72.9m
10th Dec 20207:00 amRNSTrading update and segmental restatement
26th Nov 20202:07 pmRNSHolding(s) in Company
16th Nov 202011:42 amRNSHolding(s) in Company
5th Nov 202012:01 pmRNSHolding(s) in Company
22nd Oct 20204:25 pmRNSHolding(s) in Company
7th Oct 20201:02 pmRNSHolding(s) in Company
2nd Oct 20201:37 pmRNSDirector/PDMR Shareholding
1st Oct 20204:53 pmRNSTotal Voting Rights
29th Sep 20207:00 amRNSCOO Appointment
18th Aug 20201:21 pmRNSHolding(s) in Company
12th Aug 20204:33 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSMoney20/20 US and Europe 2020 cancellations
31st Jul 202012:10 pmRNSExternal Directorship
27th Jul 20207:05 amRNSAppointment of Non-Executive Director
27th Jul 20207:00 amRNSHalf-year Report
21st Jul 20204:14 pmRNSNotice of Interim Results date
6th Jul 202012:00 pmRNSHolding(s) in Company
6th Jul 202011:59 amRNSHolding(s) in Company
11th Jun 20204:00 pmRNSDirector Declaration
2nd Jun 202011:14 amRNSTotal Voting Rights
18th May 202010:06 amRNSDirector/PDMR Shareholding
7th May 20202:44 pmRNSDirector/PDMR Shareholding
6th May 20201:35 pmRNSResult of AGM
1st May 202011:33 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCovenant amendments and Q1 trading update
21st Apr 20205:02 pmRNSHolding(s) in Company
20th Apr 20204:38 pmRNSUpdate on 2020 AGM
16th Apr 20205:02 pmRNSHolding(s) in Company
3rd Apr 20202:30 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSCannes Lions Cancellation & Other Actions
2nd Apr 20201:00 pmRNSEdge by Ascential launches Market Share 2.0
1st Apr 20205:23 pmRNSTotal Voting Rights
24th Mar 20202:00 pmRNSMoney20/20 Europe deferral to September 2020
18th Mar 20201:00 pmRNSCannes Lions deferral to contingency dates
17th Mar 20207:00 amRNSTransaction in Own Shares
16th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20209:37 amRNSHolding(s) in Company
12th Mar 20205:51 pmRNSTransaction in Own Shares
11th Mar 20205:26 pmRNSTransaction in Own Shares
11th Mar 202012:00 pmRNSContingency Dates - Cannes Lions & Money20/20 Eu
10th Mar 20205:39 pmRNSTransaction in Own Shares
9th Mar 20205:21 pmRNSTransaction in Own Shares
6th Mar 20204:57 pmRNSTransaction in Own Shares
5th Mar 20205:04 pmRNSTransaction in Own Shares
4th Mar 20205:32 pmRNSTransaction in Own Shares
3rd Mar 20204:42 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.